Literature DB >> 15075515

Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men.

Alison Morris1, Lawrence A Kingsley, Gena Groner, Irina P Lebedeva, Charles B Beard, Karen A Norris.   

Abstract

BACKGROUND: The epidemiology and transmission of Pneumocystis are poorly understood. The incidence of colonization, or detection of organisms without signs of disease, has been debated, and risk factors for colonization are largely unknown.
OBJECTIVE: To determine the rate of Pneumocystis colonization among HIV-infected patients at autopsy and analyze associated clinical variables.
METHODS: Subjects were selected from the Multicenter AIDS Cohort Study. Subjects who died from causes other than Pneumocystis pneumonia and consented to autopsy were included in analysis. DNA was extracted from lung tissue, and nested PCR was performed to detect the presence of Pneumocystis. Clinical data were obtained from the Multicenter AIDS Cohort database. Univariate and multivariate analyses were performed to determine predictors of Pneumocystis colonization.
RESULTS: Pneumocystis DNA was detected in 42 of 91 (46%) subjects by nested PCR. Clinical variables such as CD4 cell count, use of Pneumocystis prophylaxis or antiretroviral drugs, and history of previous Pneumocystis pneumonia were not related to risk of colonization. Multivariate analysis demonstrated that cigarette smoking was related to an increased risk of colonization [odds ratio (OR), 4.5; 95% confidence interval (CI), 1.27-15.6; P = 0.02] and risk also varied by city of residence (OR, 0.12; 95% CI, 0.03-0.45; P = 0.002 for living in Los Angeles).
CONCLUSIONS: This study found a high rate of Pneumocystis colonization among HIV-infected patients. We also identified cigarette smoking and city of residence as novel, independent risk factors for colonization. The role of subclinical colonization in disease transmission and the effects of Pneumocystis colonization on the lung require further study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075515     DOI: 10.1097/00002030-200403260-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  44 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

Authors:  Timothy W Shipley; Heather M Kling; Alison Morris; Sangita Patil; Jan Kristoff; Siobhan E Guyach; Jessica E Murphy; Xiuping Shao; Frank C Sciurba; Robert M Rogers; Thomas Richards; Paul Thompson; Ronald C Montelaro; Harvey O Coxson; James C Hogg; Karen A Norris
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

3.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

4.  Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia.

Authors:  Amalia Del Palacio; Maria Soledad Cuétara; Jara Llenas-García; Maria Elena Alvarez; Fernando Chaves; Federico Pulido; Mercedes Catalán; José Pontón; Valerio Del Bono; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2010-01

5.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

6.  Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study.

Authors:  Tony Antoniou; Zhan Yao; Janet Raboud; Andrea S Gershon
Journal:  CMAJ Open       Date:  2020-02-18

Review 7.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

8.  Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania.

Authors:  Lotte Jensen; Andreas V Jensen; George Praygod; Jeremiah Kidola; Daniel Faurholt-Jepsen; John Changalucha; Nyagosya Range; Henrik Friis; Jannik Helweg-Larsen; Jorgen S Jensen; Aase B Andersen
Journal:  BMC Infect Dis       Date:  2010-05-28       Impact factor: 3.090

9.  Post-mortem histological pulmonary analysis in patients with HIV/AIDS.

Authors:  Alexandre de Matos Soeiro; André L D Hovnanian; Edwin Roger Parra; Mauro Canzian; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  Pneumocystis jirovecii transmission from immunocompetent carriers to infant.

Authors:  Laura Rivero; Carmen de la Horra; Marco A Montes-Cano; Alfonso Rodríguez-Herrera; Nieves Respaldiza; Vicente Friaza; Rubén Morilla; Sonia Gutiérrez; José M Varela; Francisco J Medrano; Enrique J Calderón
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.